Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Invitae's Business Segments
Invitae's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 121
Regions Reported
1
Invitae does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - FY
- Rest of World3.5%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Rest of World | $ 4 | 3.5% |
Revenue by Product & Service Category - FY
- Diagnostic Tests97%
- Oncology43.6%
- Women's Health18.3%
- Rare Diseases12.8%
- Data and Services7.7%
- Collaboration and Genome Network3%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Diagnostic Tests | $ 118 | 97% |
| Oncology | $ 53 | 43.6% |
| Women's Health | $ 22 | 18.3% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Invitae
Invitae Corporation is a leading medical genetics company that provides genomic information to patients and healthcare providers through diagnostic tests and proactive research. The company was founded in 2010 and is headquartered in San Francisco, California.
Invitae's mission is to improve healthcare by making genetic testing accessible and affordable to everyone. The company's platform offers a comprehensive suite of tests that covers a wide range of genetic conditions, from rare diseases to complex disorders. Its offerings include genetic testing for cancer, neurology, cardiology, pediatrics, and reproductive health.
Invitae's diagnostic tests are performed using state-of-the-art technologies and are designed to deliver accurate and reliable results. The company has a team of genetic counselors and medical professionals who provide pre- and post-test counseling to patients and healthcare providers. Invitae's genetic testing service is also supported by a proprietary software platform, which facilitates the interpretation and reporting of test results.
In addition to its diagnostic testing services, Invitae is also actively involved in genomic research. The company collaborates with academic institutions and research organizations to gather and analyze genetic data, with the goal of advancing the understanding of genetic diseases and developing new treatments.
Invitae's business model is built on a pay-per-test approach, which allows healthcare providers and patients to order tests as needed. This approach has enabled the company to offer affordable testing options and drive adoption of genetic testing in the healthcare market.
Since its founding, Invitae has rapidly gained traction in the medical genetics field, with a growing customer base and revenue. The company has also expanded its operations to include international markets, with an established presence in Canada, Australia, and Europe.
In summary, Invitae Corporation is a leading medical genetics company that provides comprehensive genetic testing services to patients and healthcare providers. Its mission is to improve healthcare by making genetic testing accessible and affordable, and its platform offers a wide range of diagnostic tests and genomic research solutions. With its innovative business model and commitment to advancing genetic science, Invitae is poised to continue leading the way in the medical genetics industry.
Invitae's mission is to improve healthcare by making genetic testing accessible and affordable to everyone. The company's platform offers a comprehensive suite of tests that covers a wide range of genetic conditions, from rare diseases to complex disorders. Its offerings include genetic testing for cancer, neurology, cardiology, pediatrics, and reproductive health.
Invitae's diagnostic tests are performed using state-of-the-art technologies and are designed to deliver accurate and reliable results. The company has a team of genetic counselors and medical professionals who provide pre- and post-test counseling to patients and healthcare providers. Invitae's genetic testing service is also supported by a proprietary software platform, which facilitates the interpretation and reporting of test results.
In addition to its diagnostic testing services, Invitae is also actively involved in genomic research. The company collaborates with academic institutions and research organizations to gather and analyze genetic data, with the goal of advancing the understanding of genetic diseases and developing new treatments.
Invitae's business model is built on a pay-per-test approach, which allows healthcare providers and patients to order tests as needed. This approach has enabled the company to offer affordable testing options and drive adoption of genetic testing in the healthcare market.
Since its founding, Invitae has rapidly gained traction in the medical genetics field, with a growing customer base and revenue. The company has also expanded its operations to include international markets, with an established presence in Canada, Australia, and Europe.
In summary, Invitae Corporation is a leading medical genetics company that provides comprehensive genetic testing services to patients and healthcare providers. Its mission is to improve healthcare by making genetic testing accessible and affordable, and its platform offers a wide range of diagnostic tests and genomic research solutions. With its innovative business model and commitment to advancing genetic science, Invitae is poised to continue leading the way in the medical genetics industry.
Invitae Corporation is an innovative leader in the field of medical genetics, focused on delivering a broad spectrum of products and services aimed at both clinical and non-clinical applications within the realm of genetic testing. In a rapidly evolving landscape where genetic information is increasingly pivotal for personalized medicine, Invitae stands as a prominent entity committed to making genetic insights accessible, accurate, and affordable.
Segments
1. Clinical Segment:
The clinical segment primarily focuses on providing genetic testing services that assist healthcare providers and patients in the diagnosis, management, and treatment of various genetic disorders. This segment includes testing for hereditary conditions across multiple disciplines, aiming to provide actionable insights that inform healthcare decisions. The clinical offerings can significantly impact patient care and reproductive health by identifying genetic predispositions to diseases.
2. Non-Clinical Segment:
In contrast, the non-clinical segment targets research applications, supporting various sectors such as pharmaceutical companies, academic institutions, and research organizations. This segment encompasses genetic testing services used for drug development, biomarker discovery, and population studies, aiding in the advancement of knowledge and innovation in medical science.
Products
1. Genetic Testing Panels:
Invitae offers an extensive array of genetic testing panels designed to assess a variety of genetic conditions commonly associated with:
- Cancer: Comprehensive panels targeting hereditary cancers provide essential insights that guide surveillance and preventive strategies.
- Cardiovascular Disorders: Panels tailored to identify genetic mutations that may increase the risk of heart diseases and inform treatment options.
- Neurology: Testing for genetic factors associated with neurological conditions helps in diagnosis and management.
- Pediatrics: Panels aimed at detecting genetic disorders in children, allowing for early intervention and tailored health strategies.
- Reproductive Health: Focused on conditions that may affect reproduction, these panels aid expectant parents in understanding potential risks.
2. Carrier Screening:
Invitae’s carrier screening solutions enable individuals and couples, particularly those planning to have children, to assess their risk of passing on genetic disorders. This comprehensive testing provides valuable information that allows for informed family planning and reproductive choices.
3. Exome Sequencing:
The exome sequencing product analyzes the protein-coding regions of an individual’s genome, identifying mutations that may lead to genetic disorders. This test is particularly useful for diagnosing cases where standard panels do not provide conclusive results, catering to complex conditions where a deeper genetic analysis is warranted.
4. Pharmacogenomic Testing:
By assessing an individual’s genetic makeup, Invitae’s pharmacogenomic testing predicts how they may respond to certain medications. This personalized approach ensures that treatment regimens are optimized for efficacy and safety, enhancing the overall quality of care.
Services
1. Clinical Genetic Testing:
Invitae’s clinical genetic testing services facilitate the identification and understanding of genetic disorders for healthcare providers and their patients. The tests are structured to deliver reliable results that can guide diagnostics and therapeutic decisions.
2. Genetic Counseling:
To support individuals navigating the complexities of genetic testing, Invitae offers robust genetic counseling services. Expert counselors provide vital information on the significance of test results, potential outcomes, and implications for family planning, ensuring patients and clinicians make informed choices.
3. Clinical Trial Services:
Invitae collaborates with pharmaceutical and biotech companies by offering genetic testing services tailored for clinical trials. This support plays a crucial role in advancing research and developing new therapies, enhancing the robustness of clinical studies through genetic insights.
4. Variant Classification:
Invitae provides comprehensive variant classification services that play an essential role in identifying the significance of genetic variants detected during testing. Accurate interpretation helps guide clinical decision-making and therapeutic interventions, ensuring that healthcare providers and patients receive critical information that is both relevant and actionable.
Conclusion
In summary, Invitae Corporation encompasses a diverse array of segments, products, and services dedicated to advancing the understanding and application of genetic testing in healthcare. By focusing on both clinical and non-clinical realms, Invitae not only provides vital insights for patient care but also supports ongoing medical and genetic research. Through its extensive portfolio, which includes testing panels, carrier screenings, advanced sequencing technologies, and comprehensive support services, Invitae is positioned as a pioneer in making genetic testing accessible and impactful, ultimately transforming the landscape of precision medicine.
Segments
1. Clinical Segment:
The clinical segment primarily focuses on providing genetic testing services that assist healthcare providers and patients in the diagnosis, management, and treatment of various genetic disorders. This segment includes testing for hereditary conditions across multiple disciplines, aiming to provide actionable insights that inform healthcare decisions. The clinical offerings can significantly impact patient care and reproductive health by identifying genetic predispositions to diseases.
2. Non-Clinical Segment:
In contrast, the non-clinical segment targets research applications, supporting various sectors such as pharmaceutical companies, academic institutions, and research organizations. This segment encompasses genetic testing services used for drug development, biomarker discovery, and population studies, aiding in the advancement of knowledge and innovation in medical science.
Products
1. Genetic Testing Panels:
Invitae offers an extensive array of genetic testing panels designed to assess a variety of genetic conditions commonly associated with:
- Cancer: Comprehensive panels targeting hereditary cancers provide essential insights that guide surveillance and preventive strategies.
- Cardiovascular Disorders: Panels tailored to identify genetic mutations that may increase the risk of heart diseases and inform treatment options.
- Neurology: Testing for genetic factors associated with neurological conditions helps in diagnosis and management.
- Pediatrics: Panels aimed at detecting genetic disorders in children, allowing for early intervention and tailored health strategies.
- Reproductive Health: Focused on conditions that may affect reproduction, these panels aid expectant parents in understanding potential risks.
2. Carrier Screening:
Invitae’s carrier screening solutions enable individuals and couples, particularly those planning to have children, to assess their risk of passing on genetic disorders. This comprehensive testing provides valuable information that allows for informed family planning and reproductive choices.
3. Exome Sequencing:
The exome sequencing product analyzes the protein-coding regions of an individual’s genome, identifying mutations that may lead to genetic disorders. This test is particularly useful for diagnosing cases where standard panels do not provide conclusive results, catering to complex conditions where a deeper genetic analysis is warranted.
4. Pharmacogenomic Testing:
By assessing an individual’s genetic makeup, Invitae’s pharmacogenomic testing predicts how they may respond to certain medications. This personalized approach ensures that treatment regimens are optimized for efficacy and safety, enhancing the overall quality of care.
Services
1. Clinical Genetic Testing:
Invitae’s clinical genetic testing services facilitate the identification and understanding of genetic disorders for healthcare providers and their patients. The tests are structured to deliver reliable results that can guide diagnostics and therapeutic decisions.
2. Genetic Counseling:
To support individuals navigating the complexities of genetic testing, Invitae offers robust genetic counseling services. Expert counselors provide vital information on the significance of test results, potential outcomes, and implications for family planning, ensuring patients and clinicians make informed choices.
3. Clinical Trial Services:
Invitae collaborates with pharmaceutical and biotech companies by offering genetic testing services tailored for clinical trials. This support plays a crucial role in advancing research and developing new therapies, enhancing the robustness of clinical studies through genetic insights.
4. Variant Classification:
Invitae provides comprehensive variant classification services that play an essential role in identifying the significance of genetic variants detected during testing. Accurate interpretation helps guide clinical decision-making and therapeutic interventions, ensuring that healthcare providers and patients receive critical information that is both relevant and actionable.
Conclusion
In summary, Invitae Corporation encompasses a diverse array of segments, products, and services dedicated to advancing the understanding and application of genetic testing in healthcare. By focusing on both clinical and non-clinical realms, Invitae not only provides vital insights for patient care but also supports ongoing medical and genetic research. Through its extensive portfolio, which includes testing panels, carrier screenings, advanced sequencing technologies, and comprehensive support services, Invitae is positioned as a pioneer in making genetic testing accessible and impactful, ultimately transforming the landscape of precision medicine.